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[73.2 (15.4)] and did not improve over time. 76% had behavioural
disorders already evident during hospitalization. Upon discharge, 62%
required adapted and/or specialized schooling. After an average
follow-up of 8 and a half years, only 6 patients still followed an
ordinary curriculum and 8 were not attending school anymore. Four
girls were victims, and among 36 boys, all were perpetrators, but 3
had been victims previously. The offenses were mainly cases of
violence (56%), but also entailed thefts, trafﬁc offences, sexual
assaults, drug use and vandalism.
Discussion Children with ABI who suffer or commit offenses are
mainly boys, from very low socioeconomic background, with pre-
injury academic and social difﬁculties, who sustained severe TBI.
They suffer very severe and disabling cognitive deﬁcits and
behavioral disorders. Multidisciplinary care and follow-up of those
children more at risk is essential in the long-term.
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Introduction Craniopharyngioma is a rare, benign central ner-
vous system tumor, which may be source of multiple complica-
tions, from endocrinology to vision, neurology and neurocognitive
fonctions. This morbidity can lead to participation restrictions, as
described in the International Clasiﬁcation of Functioning. Primary
objective of this studywas tomeasure participation in a population
of children and young adults having been affected by a childhood
carniopharyngioma, using the LIFE-H questionnaire (Assessment
of Life Habits), valid as a participationmeasure in various pediatric
disabilities. We also examined potential links between the tumor
characteristics, the complications and the participation.
Patients and methods Descriptive, multicenter study, including
all patients having presented a childhood craniopharyngioma
(before 18), followed in Lyon region between 2007 and 2013. Main
criteria was the LIFE-H results, completed by the patient or the
carer.
Results On 21 patients included in the study, 14 have completed
the questionnaire, with a mean answer delay of 6.7 years after the
diagnosis (SD: 3.9 years). Mean total LIFE-H score was 8.4 (SD:
1.03) for a normal score estimated at 10 in general population. The
lowest scores affected nutrition, community life and recreation
dimensions. All patients had a endocrinological deﬁcit, 19% an
hypothalamic syndrome, 52% an impaired fullﬁlness feeling, 76%
visual impairment, 14% a neurologic impairment, 91% a neuro-
cognitive impairment. 57% of all patients could keep on attending a
normal school, 43% had to enter a speciﬁc school. In patients in
speciﬁc school, LIFE-H results were signiﬁcantly lower in nutrition,
communication, housing and recreation dimensions.
Conclusion Patients with childhood craniopharyngioma have
their participation affected, mainly in the social dimensions. We
could enhance it with systematic diagnosis of those participation
impairements, with the goal of a suitable multidisciplinary
management.
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Objectives Assessing muscle function is a key step in measuring
changes and evaluating the outcomes of therapeutic interventions
in Duchenne Muscular Dystrophy (DMD). Regarding the large use
of corticosteroids (CS) in this population to delay the loss of
function, our goal was to monitor the evolution of motor function
in patients with DMD treated by corticosteroids (CS) and to study
the responsiveness of Motor Function Measure (MFM) in this
population in order to provide an estimation of the number of
subject needed for a clinical trial.
Method A total of 76 patients with DMD, aged 5.9 to 11.8 years,
with at least 6months of follow-up and 2MFMwere enrolled, 30 in
the CS treated group (8  1.62 y) and 46 in the untreated group
(7.91  1.50 y).
Results The relationship between MFM scores and age was
studied in CS treated patients and untreated patients. The
evolution of these scores was compared between groups, on a
6-, 12- and 24-month period by calculating slopes of change and
standardized response mean. At 6, 12 and 24 months, signiﬁcant
differences in the mean score change were found, for all MFM
scores, between CS treated patients and untreated patients. For D1
subscore speciﬁcally, at 6 months, the increase is signiﬁcant in the
treated group (11.3  14%/y; SRM 0.8) while a decrease is observed
in the untreated group (–17.8  17.7%/y; SRM 1). At 12 and 24
months, D1 subscore stabilized for treated patients but declined
signiﬁcantly for untreated boys (–15.5  15.1%/y; SRM 1 at 12 mo
and–18.8  7.1%/y; SRM 2.6 at 24 mo). 21 patients lost the ability to
walk during the study: 6 in the CS treated group (25% at 24 months,
mean age: 10.74  1.28 y) and 15 in the untreated group (64.71% at
24 months, mean age: 9.20  1.78 y).
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Discussion and conclusion Patients with DMD treated by CS
present a different course of the disease described in this paper
using the MFM. Based on these results, an estimation of the
number of patients needed for clinical trial could be done.
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Introduction Linear scleroderma morphea is a subtype of
localized scleroderma which mainly affects children and is
sometimes complicated by bone and joint deformities. Its location
at the foot is rarely reported.
Aim of study Describe the clinical and anatomical deformity of
the foot and ankle in children with linear scleroderma and chat
support, from a clinical case and a review of the literature.
Observation An 8-year-old boy followed for Linear morphea was
addressed to the consultation of physical medicine and rehabilita-
tion for rehabilitation care and casting of a deformation of the right
foot. Physical examination found skin lesions in the thigh and right
ankle, a paretic right lower limb, an inequality of length of 3 cm
lower right limb, with stiffness in his right ankle. Walking is done
with lameness and attack the forefoot, the review found
podoscopic grade hollow legs [1] with calcaneal valgus more
pronounced on the right. The management consisted of a
background treatment with corticosteroids, a functional rehabili-
tation and suitable equipment.
Discussion/conclusion Scleroderma focal length of the child’s foot
is a rare and can be associated with irreducible and scalable
orthopedic deformities. Early diagnosis, extensive surgical release
in the event of severe and progressive orthopedic deformation,
followed by physiotherapy and extended equipment, represent the
main elements of the management.
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Background Nowadays, paediatric CRPS is a recognized disease
with its own speciﬁcities compared to the adult CRPS. However, its
treatment is difﬁcult and there is sparse consensus among the
management of those patients, partly due to a usually delayed
diagnosis and a complex multifactorial pathogenicity including
osteoarticular, neurological and psychological issues. Everyone
agrees that the management of these patients should be
multidisciplinary including physiotherapy, occupational therapy,
psychotherapy and medication.
Case report We are sharing our experience with two severe cases
of paediatric CRPS type I involving the foot, a boy and a girl aged 12
and 11 respectively at the time of diagnosis. Symptoms were
hyperalgesia, oedema, bone demineralisation on the radiological
exams and a disturbed psychological proﬁle. After the failure of
different outpatient treatments, we decided to hospitalise them in
the Department of Paediatrics Orthopaedics. The protocol of
treatment followed a very strict and intensive daily schedule
including multiple therapies in physiotherapy and occupational
therapies (balneotherapy, music therapy, progressive desensitiza-
tion, TENS, walking rehabilitation), the use of pain killers, a follow-
up by a paediatric psychiatrist, a referent nurse, and a limitation to
the family visiting hours. After 1 to 2 weeks, a signiﬁcant
improvement was seen and after 6 months, pain had disappeared
and weight-bearing was possible for both children.
Discussion To this daywe do not know the intensity and duration
necessary to treat efﬁciently a paediatric CRPS. The hospitalisation
is considered as the last resort for the management of CRPS, but it
allows a close observation of the patient, the opportunity to take
her/him out of his family and an intensive multidisciplinary
treatment that is impossible as an outpatient. The precise factors
allowing the treatment’s success are still not clear, but they could
be a combination of intensive therapy and/or thewithdrawal of the
patient from his family. Nonetheless it seems that a strict and
intensive protocoled schedule, as an inpatient beneﬁts the
management of severe cases of CRPS.
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